New Approaches To Clot Removal With Lower Extremity DVT Announced At The VEITH Symposium

Main Category: Vascular
Also Included In: Blood / Hematology
Article Date: 24 Nov 2008 - 2:00 PDT

email to a friend   printer friendly   opinions  

With the recent recognition that thrombolysis should be considered in first time proximal deep vein thrombosis (DVT), the quest for the best agents and the best delivery systems remains the challenge.

The role for thrombolysis in DVT is more accepted than ever and is now being considered as a main line therapy for large, proximal, occlusive DVTs. Georg H. Meier III, M.D., Professor of Surgery at the University of Cincinnati College of Medicine and Chief, Vascular Surgery, at the University Hospital in Cincinnati, Ohio, finds that younger patients are benefited by thrombolytic therapy for the duration of their lives.

This prolonged benefit makes any additional risk of treatment less of a factor. Similarly, the risk of thrombolysis is less in younger patients since other disease processes that increase bleeding risk are less common.

With the widespread use of the AngioJet mechanical thrombectomy device, management of DVT changed and the combination of mechanical device with thrombolysis infusion became the standard. Newer devices promise to speed the catheter component of thrombolysis further.

For many years it has been known that ultrasound speeds thrombolysis. Thrombolysis for DVT is increasing used as a mainstay for therapy in first time DVT. While there are a number of approaches to performing DVT thrombolysis, the challenge remains gaining consideration of thrombolytic therapy in patients appropriate for treatment.

Newer techniques for lysis delivery will alter our treatment in the future, but further experience and study is needed to better define the clinical approaches once thrombolysis is selected.

VEITH SYMPOSIUM - New York, November 19th to 23rd

Now in its fourth decade, VEITH SYMPOSIUM provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques.

VEITHsymposium is sponsored by Cleveland Clinic, Cleveland, OH.

www.veithsymposium.org

Source
Pauline T. Mayer
www.ptmhcm.com

• Additional
• References
• Citations